N = 74 No (%)

Character

55 (74.3)

9 (12.2%)

5 (6.8)

5 (6.8)

Pathology of the tumor

IDC

IDC with diffuse DCIS

ILC

Phylloides tumor

5 (6.8)

7 (9.5%)

10 (13.5)

33 (44.6)

19 (25.7)

TNM stage

>10 cm

T1N0M0

T2N0M0

T2N1M0

T3N1M0

19 (25.7)

Neo-adjuvant chemotherapy

50 (67.5)

Adjuvant chemotherapy

69 (93%)

Hormonal therapy

52 (70.3)

Adjuvant radiotherapy

28 (37.8)

16 (21.6)

20 (27)

10 (13.5)

Incision approach

Elliptical incision

Peri-areolar incision

Lateral mammary fold incision

Infra-mammary incision

5 (6.8)

59 (79.7)

10 (13.5)

Axillary incision

Un needed

Through the same incision approach

Through separate incision

5 (6.8)

51 (68.9)

18 (24.3)

Axillary management

Un needed

Formal evacuation

SLN

14 (18.9)

Implant insertion

10 (13.5)

4 (5.4)

25 (33.8)

10 (13.5)

4 (5.4)

4 (5.4)

5 (6.8)

2 (2.7)

Complications

NAC necrosis

Donor site haemorrhage

Donor site seroma formation

Resection site seroma formation

Donor site wound evisceration

Donor site wound infection

Breast wound infection

Exposure of implant